Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Berberine in Treating Negative Symptoms of Schizophrenia: Clinical Efficacy and Mechanisms

NCT07356765 is registered in ClinicalTrials.gov with Tianjin Anding Hospital as lead sponsor.

NCT NCT07356765
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07356765 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Berberine in Treating Negative Symptoms of Schizophrenia: Clinical Efficacy and Mechanisms
Lead sponsor
Tianjin Anding Hospital
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
September 26, 2023
Completion date
April 30, 2027
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

negative symptoms of schizophrenia, schizophrenia